Τετάρτη 24 Μαΐου 2017

Haematological cancer: Pembrolizumab is effective in multiple myeloma.

Haematological cancer: Pembrolizumab is effective in multiple myeloma.

Nat Rev Clin Oncol. 2017 May 23;:

Authors: Sidaway P

PMID: 28534530 [PubMed - as supplied by publisher]



http://ift.tt/2qV5Doi

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου